Home  |  Contact

Cellosaurus HVEM 18.10 (CVCL_B7FA)

[Text version]
Cell line name HVEM 18.10
Accession CVCL_B7FA
Resource Identification Initiative To cite this cell line use: HVEM 18.10 (RRID:CVCL_B7FA)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4752.
Monoclonal antibody isotype: Not specified.
Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270.
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy Parent: CVCL_4032 (P3X63Ag8.653)
Category Hybridoma
Publications

PubMed=23692853; DOI=10.1182/blood-2012-11-464685
Gertner-Dardenne J., Fauriat C., Orlanducci F., Thibult M.-L., Pastor S., Fitzgibbon J., Bouabdallah R., Xerri L., Olive D.
The co-receptor BTLA negatively regulates human Vgamma9Vdelta2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
Blood 122:922-931(2013)

Patent=US10005839
Olive D., Pasero C., Gertner-Dardenne J.
Antagonist of the BTLA/HVEM interaction for use in therapy.
Patent number US10005839, 26-Jun-2018

Cross-references
Encyclopedic resources Wikidata; Q112929806
Entry history
Entry creation23-Jun-2022
Last entry update21-Mar-2023
Version number3